| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2018NatCo...9.5009X |
| P6179 | Dimensions Publication ID | 1110105604 |
| P356 | DOI | 10.1038/S41467-018-07308-5 |
| P932 | PMC publication ID | 6258759 |
| P698 | PubMed publication ID | 30479336 |
| P50 | author | Lin Feng | Q59698259 |
| Mu-Sheng Zeng | Q68691782 | ||
| P2093 | author name string | Yi-Xin Zeng | |
| Xiao Zhang | |||
| Miao Xu | |||
| Ming-Yuan Chen | |||
| Qi-Sheng Feng | |||
| Tong Xiang | |||
| Wenlong Ma | |||
| Ke-Ming Chen | |||
| Gui-Ping He | |||
| Hao-Jiong Zhang | |||
| Yu-Xin Lin | |||
| P2860 | cites work | Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect | Q24294513 |
| Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension | Q24307473 | ||
| Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model | Q24803460 | ||
| Tumor cell vasculogenic mimicry: from controversy to therapeutic promise | Q26829921 | ||
| Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer | Q27824855 | ||
| Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase | Q28251762 | ||
| Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma | Q82270601 | ||
| Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro | Q39927855 | ||
| Epstein-Barr virus: a master epigenetic manipulator | Q40093402 | ||
| EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells | Q40219046 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus | Q40934947 | ||
| Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue | Q42930541 | ||
| Epstein-Barr virus at 50-future perspectives | Q43035017 | ||
| 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. | Q44426540 | ||
| Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle | Q45413006 | ||
| Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma. | Q52581305 | ||
| Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. | Q53646118 | ||
| TNFRSF19 inhibits TGFβ signaling through interaction with TGFβ receptor type I to promote tumorigenesis. | Q53686619 | ||
| mTOR Signaling in Growth, Metabolism, and Disease. | Q54144950 | ||
| Epstein-Barr virus and nasopharyngeal carcinoma | Q56947843 | ||
| Epstein-Barr virus activates F-box protein FBXO2 to limit viral infectivity by targeting glycoprotein B for degradation | Q59355883 | ||
| Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation | Q59647283 | ||
| The enigmatic epidemiology of nasopharyngeal carcinoma | Q28268076 | ||
| CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections | Q28552274 | ||
| Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia | Q30399006 | ||
| Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma | Q33598586 | ||
| HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment | Q33612891 | ||
| Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A. | Q33754907 | ||
| Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma | Q33818584 | ||
| Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter. | Q33842381 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications | Q34265783 | ||
| Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha | Q34346992 | ||
| Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF-1α-neuropilin-1 axis | Q34491119 | ||
| Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells | Q34564031 | ||
| Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas | Q34605336 | ||
| Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma | Q35141769 | ||
| Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines | Q35363169 | ||
| Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations | Q35693266 | ||
| Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway | Q35948025 | ||
| Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells | Q36135900 | ||
| Integration of oxygen signaling at the consensus HRE. | Q36290265 | ||
| Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation | Q36971030 | ||
| Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. | Q37175573 | ||
| Vasculogenic mimicry in small cell lung cancer | Q37408684 | ||
| Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer | Q37513086 | ||
| Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity | Q37938966 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 | ||
| Passing the baton: the HIF switch | Q38028020 | ||
| Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer | Q38072462 | ||
| Antiangiogenic therapies: going beyond their limits | Q38172781 | ||
| The role of Epstein-Barr virus in epithelial malignancies | Q38253914 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers | Q38805572 | ||
| Epstein-Barr virus: more than 50 years old and still providing surprises. | Q38968588 | ||
| Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. | Q39585482 | ||
| Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. | Q39878386 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | general chemistry | Q909510 |
| vasculogenesis | Q1424593 | ||
| P304 | page(s) | 5009 | |
| P577 | publication date | 2018-11-27 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Vasculogenic mimicry formation in EBV-associated epithelial malignancies | |
| P478 | volume | 9 |
| Q90483485 | Alterations in cellular expression in EBV infected epithelial cell lines and tumors |
| Q91578745 | Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma |
| Q96341495 | Epstein-Barr virus-encoded miR-BART11 promotes tumor-associated macrophage-induced epithelial-mesenchymal transition via targeting FOXP1 in gastric cancer |
| Q99413584 | Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis |
| Q89983819 | Gastric cancer: genome damaged by bugs |
| Q64884992 | Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis. |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q64069946 | Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinoma |
| Q90310191 | Vasculogenic mimicry in carcinogenesis and clinical applications |
Search more.